Clinical Trials Logo

Clinical Trial Summary

Little is known regarding the effectiveness of neonatal oral hygiene and its relationship to colonization by Candida spp. in edentulous oral cavities. Thus, the objective of this study is to evaluate whether the oral hygiene of edentulous infants favors colonization by Candida spp. Newborns with up to 48 hours of life will randomly allocated to two groups. The mothers will instructed to clean the oral cavity with gauze and mineral water three times a day, in the test group, and not to clean, in the control group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03873753
Study type Interventional
Source Faculty Sao Leopoldo Mandic Campinas
Contact Sandra Regina E. da Silva, PhD
Phone +55 11 945179999
Email secheverria@uol.com.br
Status Recruiting
Phase N/A
Start date May 2, 2017
Completion date December 30, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03250923 - CelAgaceā„¢ OraRinse Solution for Treatment of Candidiasis Phase 1/Phase 2
Completed NCT00004781 - Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups N/A
Completed NCT03894839 - Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species N/A
Completed NCT00128323 - A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis Phase 3
Recruiting NCT04410250 - Effect of Oral Hygienization in Newborn on Candida Spp Colonization N/A
Completed NCT02184351 - Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis Phase 3
Completed NCT00665639 - Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis Phase 3
Completed NCT02818803 - Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic Phase 3
Recruiting NCT06120816 - Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis Phase 1
Completed NCT00235053 - Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID Phase 4
Completed NCT00666185 - Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis Phase 3
Completed NCT00002446 - Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients Phase 3
Completed NCT00001448 - The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection N/A
Completed NCT00612963 - Novel Rinse to Treat in Oral Candidiasis in Cancer Patients N/A
Completed NCT00001812 - A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 Phase 3
Completed NCT00002394 - Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment N/A
Completed NCT00002282 - A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS N/A
Completed NCT00002341 - A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole N/A
Completed NCT00000951 - A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush Phase 4
Completed NCT00002133 - An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects. N/A